Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,412	4,506	3,499	2,040	1,742	1,182
Market Cap Growth	28.76%	28.76%	71.56%	17.08%	47.34%	23.36%
Enterprise Value	4,669	3,819	2,909	1,642	1,388	899
Last Close Price	187.86	156.66	124.06	79.22	69.95	60.00
PE Ratio	62.62	50.53	320.09	-	-	-
Forward PE	25.93	33.30	-	-	-	-
PS Ratio	18.49	15.51	69.02	-	-	-
PB Ratio	5.72	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	4.76	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	45.41	37.80	-	-	-	-
P/OCF Ratio	43.85	36.51	-	-	-	-
EV/Sales Ratio	16.07	13.15	57.38	-	-	-
EV/EBITDA Ratio	42.77	34.98	-	-	-	-
EV/EBIT Ratio	45.25	37.01	-	-	-	-
EV/FCF Ratio	39.18	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.07	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.31	0.31	0.07	-	-	-
Inventory Turnover	1.20	1.20	-	-	-	-
Quick Ratio	6.89	6.89	17.35	13.14	17.02	17.56
Current Ratio	7.28	7.28	17.76	13.30	17.18	17.80
Return on Equity (ROE)	10.34%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	6.88%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	7.41%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	10.82%	10.82%	-	-	-	-
Earnings Yield	1.65%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.20%	2.65%	-2.87%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-7.16%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%
Total Shareholder Return	-7.16%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Source: S&P Capital IQ. Standard template. Financial Sources.